Dolat Capital: Torrent Pharma Q2 Revenue In-Line With Estimates, Priced To Perfection  
An employee scoops up tablet cores for inspection at a pharmaceutical plant. (Photographer Hannelore Foerster/Bloomberg)

Dolat Capital: Torrent Pharma Q2 Revenue In-Line With Estimates, Priced To Perfection  

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer Bl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.